SW

Samuel Watson

Bioxyne Limited | Chief Executive Officer, Managing Director
Mr Watson founded Breathe Life Sciences (BLS) in 2020 with business partner and co-director Ian Owles MPS, CFMP (certified functional medicines practitioner). BLS has quickly become a player in the health and wellness industry in Europe, UK, and Japan.

Company and Roles

Company
Title
Tenure
Since
BXN
BXN
Bioxyne Limited
  • Chief Executive Officer
  • Managing Director
1yrs, 3mthMay 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BXN
BXN
Bioxyne Limited
13/10/23999,362634,001,384N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BXN
BXN
Bioxyne Limited
13/10/23
Buy
20,000,000$0.013$250,000Off-market trade
BXN
BXN
Bioxyne Limited
12/10/23
Buy
999,362$0.014$14,000On-market trade